Work

Hyperimmune immunoglobulin for people with COVID-19

Year: 2021

Type: article

Study design: Study Protocol

Abstract: Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. Using a living systematic review approach, to assess whether hyperimmune immunoglobulin therapy is effective and safe in the treatment of people with COVID-19; and to maintain the currency of the evidence.

Source: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858.cd015167

Authors: Catherine Kimber, Sarah J Valk, Khai Li Chai, Vanessa Piechotta, Claire Iannizzi, Ina Monsef, Erica M Wood, Abigail A Lamikanra, David J Roberts, Zoe McQuilten, Cynthia So-Osman, Lise J Estcourt, Nicole Skoetz

Institutions: Leiden University Medical Center, Sanquin, Jon J van Rood Centre for Clinical Transfusion Research, Monash University, University of Cologne, University Hospital Cologne, NHS Blood and Transplant

Language: English

Topic: COVID-19 Clinical Research Studies

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Emory University, NHS Blood and Transplant, National Institute for Health and Care Research, European Commission, Universität zu Köln

Awards: SUPporting high quality evaluation of COVID-19 convalescent Plasma thrOughoutT Europe, G434337789

OpenAlex ID: W3205492675

FWCI:

Cites: 66

Cited by:

Related to: 10